Moderate selenium dosing inhibited chromium (VI) toxicity in chicken liver

This study aimed to clarify the effect of selenium (Se) on chromium (VI) [Cr(VI)]-induced damage in chicken liver. A total of 105 chickens were randomly divided into seven groups of 15. Group I received deionized water; group II received Cr(VI) (7.83mg/kg/d) alone; and other groups orally received both Cr(VI) (7.83mg/kg/d) and Se of different doses (0.14, 0.29, 0.57, 1.14, and 2.28mg/kg/d). The levels of superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA), Ca2+-ATPase, and mitochondrial membrane potential (MMP) were measured. Results showed that Cr(VI) increased MDA content and decreased GSH content, T-SOD activity, Ca2+-ATPase activity, and MMP level. Meanwhile, Se co-treatment (0.14, 0.29, and 0.57mg/kg/d) increased the viability of the above indicators compared with Cr(VI)-treatment alone. In addition, histopathologic examination revealed that Cr(VI) can cause liver damage, whereas Se supplementation of moderate dose inhibited this damage. This study confirmed that Se exerted protective effect against Cr(VI)-induced liver damage.